Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
126.67
+1.57 (1.26%)
Nov 22, 2024, 4:00 PM EST - Market closed
Jazz Pharmaceuticals Revenue
Jazz Pharmaceuticals had revenue of $1.05B in the quarter ending September 30, 2024, with 8.52% growth. This brings the company's revenue in the last twelve months to $3.99B, up 5.23% year-over-year. In the year 2023, Jazz Pharmaceuticals had annual revenue of $3.83B with 4.78% growth.
Revenue (ttm)
$3.99B
Revenue Growth
+5.23%
P/S Ratio
1.98
Revenue / Employee
$1,425,969
Employees
2,800
Market Cap
7.66B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.83B | 174.83M | 4.78% |
Dec 31, 2022 | 3.66B | 565.14M | 18.26% |
Dec 31, 2021 | 3.09B | 730.67M | 30.91% |
Dec 31, 2020 | 2.36B | 201.81M | 9.34% |
Dec 31, 2019 | 2.16B | 270.84M | 14.32% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walgreens Boots Alliance | 147.66B |
Grifols | 7.81B |
Bausch + Lomb | 4.68B |
The Ensign Group | 4.11B |
Chemed | 2.38B |
Repligen | 633.51M |
Legend Biotech | 520.18M |
Ascendis Pharma | 365.19M |
JAZZ News
- 2 days ago - Jazz Pharmaceuticals receives FDA approval for biliary tract cancer treatment - Reuters
- 2 days ago - Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC) - PRNewsWire
- 3 days ago - Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference - PRNewsWire
- 16 days ago - Jazz Pharmaceuticals plc (JAZZ) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Jazz Pharmaceuticals Reports Strong Q3: Will Debt Weigh On Its Future Growth? - Benzinga
- 16 days ago - Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results - PRNewsWire
- 22 days ago - Jazz Pharmaceuticals Presents New Data at Psych Congress 2024 Confirming Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Benefits in Narcolepsy and Idiopathic Hypersomnia - PRNewsWire
- 4 weeks ago - Jazz Pharmaceuticals to Report 2024 Third Quarter Financial Results on November 6, 2024 - PRNewsWire